Drug Shortage Report for ACLASTA
| Report ID | 256652 |
| Drug Identification Number | 02269198 |
| Brand name | ACLASTA |
| Common or Proper name | ACLASTA |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100ML |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-05-05 |
| Estimated end date | 2025-05-16 |
| Actual end date | 2025-05-19 |
| Shortage status | Resolved |
| Updated date | 2025-05-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-05-20 | French | Compare |
| v6 | 2025-05-20 | English | Compare |
| v5 | 2025-05-12 | French | Compare |
| v4 | 2025-05-12 | English | Compare |
| v3 | 2025-05-06 | English | Compare |
| v2 | 2025-05-05 | French | Compare |
| v1 | 2025-05-05 | English | Compare |
Showing 1 to 7 of 7